BD to Announce Financial Results for its First Quarter of Fiscal 2024


Werte in diesem Artikel
Aktien

133.80 EUR -5.05 EUR -3.64 %

FRANKLIN LAKES, N.J., Jan. 4, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results for its first quarter of fiscal year 2024 on Thursday, February 1, 2024. A news release will be issued at approximately 6:30 a.m. Eastern Time (ET) and will be available at www.bd.com/investors, along with related presentation materials. The news release and presentation materials will include summary financial information for the company's first quarter of fiscal year 2024, which ended on December 31, 2023.

BD management will host an audio webcast at 8 a.m. ET on February 1, 2024 to discuss its financial results and provide an update on its operations and strategy. The audio webcast can be accessed at BD's investor relations website at www.bd.com/investors and a replay will be available shortly after the call at the same website.

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson

Contacts:










Media:




Investors:

Troy Kirkpatrick




Adam Reiffe

VP, Public Relations




Sr. Director, Investor Relations

858.617.2361




201.847.6927        

troy.kirkpatrick@bd.com




adam.reiffe@bd.com     

Cision View original content:https://www.prnewswire.com/news-releases/bd-to-announce-financial-results-for-its-first-quarter-of-fiscal-2024-302026657.html

SOURCE BD (Becton, Dickinson and Company)

Aktuelle Becton, Dickinson Aktie News

Werbung

Becton, Dickinson Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Becton, Dickinson nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
13.05.19 Becton, DickinsonCo (BD) Overweight Barclays Capital
07.12.18 Becton, DickinsonCo (BD) Buy Deutsche Bank AG
16.10.18 Becton, DickinsonCo (BD) Equal Weight Barclays Capital
09.03.18 Becton, DickinsonCo (BD) Market Perform BMO Capital Markets
29.12.17 Becton, DickinsonCo (BD) Buy Deutsche Bank AG